Showing results (1721-1730 of 2,171) with videos related to
Sort By:
Pageof 218
The Annals of Thoracic Surgery|November 26, 2015
Thirty-Day Mortality After Lobectomy in Elderly Patients Eligible for Lung Cancer ScreeningCarlos E Bravo Iñiguez, Katherine W Armstrong, Zara Cooper, et al.JACC. Heart Failure|August 11, 2023
Age, Sex, and Outcomes in Heart Failure With Reduced EF: Insights From the VICTORIA TrialCarolyn S P Lam, Ileana L Piña, Yinggan Zheng, et al.The British Journal of Dermatology|June 9, 2021
Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2K Reich, K B Gordon, B E Strober, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 10, 2023
Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin typeAndrew F Alexis, Jonathan I Silverberg, Zakiya P Rice, et al.Circulation|February 11, 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methodsKaren S Pieper, Anastasios A Tsiatis, Marie Davidian, et al.Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.Circulation|September 24, 2004
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-IPadma Kaul, Paul W Armstrong, Wei-Ching Chang, et al.European Heart Journal|May 27, 2010
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trialKurt Huber, David R Holmes, Arnoud W van 't Hof, et al.Journal of the American Academy of Dermatology|February 18, 2026
The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trialJonathan I Silverberg, Lawrence F Eichenfield, April W Armstrong, et al.European Journal of Heart Failure|July 5, 2020
Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trialFinlay A McAlister, Yinggan Zheng, Cynthia M Westerhout, et al.Pageof 218